Combination Pharmacotherapies for Obesity—Current Evidence and Future Directions
Combination pharmacotherapy for obesity can enhance weight loss by targeting complementary neuroendocrine and metabolic pathways. Such benefits are largely additive but limited by tolerability, cost and access. This review outlines practical clinical archetypes and a research agenda for safer, more precise and durable combination strategies across ...
A. B. M. Kamrul‐Hasan +6 more
wiley +1 more source
Gallbladder cancer presenting with a single giant common bile duct stone in a patient with normal cholestatic function tests: a case report. [PDF]
Shibiru YA +3 more
europepmc +1 more source
The Role and Mechanism of Incretins in Gynaecologic Diseases
This review outlines the mechanisms of incretins in polycystic ovary syndrome, endometriosis and gynaecological cancers, highlighting the translational potential of incretin‐based therapies for metabolic‐associated gynaecological disorders. ABSTRACT Background Obesity is a major global public health concern closely linked to the development and ...
Jiayu Yan +10 more
wiley +1 more source
Protein Expression Analysis and Functional Characterization of Sorcin in Gallbladder Cancer. [PDF]
Jain V +8 more
europepmc +1 more source
Taurine and Metabolic Diseases: Molecular Mechanisms and Therapeutic Implications
The dietary sources of taurine, as well as its protective effects and mechanisms in metabolism‐related diseases and metabolic disorder–associated ocular and cerebral injuries. ABSTRACT Taurine (Tau) is a sulfur‐containing amino acid prevalent in animal tissues and primarily acquired through dietary sources.
Xiaojie Ma, Zhijian Rao, Lifang Zheng
wiley +1 more source
Development and Validation of Nomogram Predicting Survival in Resectable Gallbladder Cancer. [PDF]
Patkar S +9 more
europepmc +1 more source
Cardiovascular disease incidence and cancer risk in two large European prospective cohorts
What's new? Cardiovascular disease (CVD) and cancer share risk factors and biological mechanisms, raising questions about potential associations between the two, particularly regarding CVD duration and cancer onset. Whether CVD influences subsequent cancer risk, however, remains inconclusive.
Emma Fontvieille +25 more
wiley +1 more source
Urinary bladder invasion secondary to dissemination of gallbladder cancer: an unusual presentation. [PDF]
Watanabe R +8 more
europepmc +1 more source
ABSTRACT Introduction Plasmacytoid urothelial carcinoma (PUC) is a rare, aggressive subtype of bladder cancer characterized by diffuse infiltrative growth and a propensity for peritoneal and retroperitoneal dissemination. Case Presentation A patient with muscle‐invasive bladder cancer (cT3N1M0) was diagnosed with conventional high‐grade urothelial ...
Mahito Atsuta +9 more
wiley +1 more source
Treatment of elderly patients with advanced (M1) gallbladder cancer - Aggressive or conservative?: A retrospective cohort study based on the SEER database. [PDF]
He B, Zhou T, Weng P, Lan H.
europepmc +1 more source

